1 year return (CAGR)
-18.03%
Ocular Therapeutix Inc Exchange (NASDAQ, USD)
OCUL
10.00
-0.50 (-4.76%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
44.42%
5 year return (CAGR)
-0.59%
10 year return (CAGR)
4.15%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.20B
Price/Sales
42.19
Ent value
1.75B
Price/Book
4.22
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-11.13%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 10.48 |
| Daily high | 10.57 |
| Daily low | 9.77 |
| Daily Volume | 2.09M |
| All-time high | 43.27 |
| 1y analyst estimate | 27.09 |
| Beta | 0.97 |
| EPS (TTM) | -1.34 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 9 Mar 2026 |
Downside potential
Loading...
Downside potential data
| OCUL | S&P500 | |
| Current price drop from All-time high | -76.89% | -1.29% |
| Highest price drop | -95.19% | -56.47% |
| Date of highest drop | 16 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -76.61% | -10.68% |
| Avg time to new high | 61 days | 12 days |
| Max time to new high | 2893 days | 1805 days |
News
